BC Week In Review | Aug 18, 2014
Company News

Sinovac, Beijing Centers for Disease Control and Prevention infectious news

Sinovac said the Beijing CDC selected Sinovac as a supplier of seasonal influenza vaccine to the citizens of Beijing for 2014. Sinovac said the center plans to order a minimum of 1.2 million doses of...
BC Week In Review | Apr 29, 2013
Clinical News

Anflu regulatory update

Sinovac said Mexico granted a certificate of approval to commercialize its Anflu seasonal flu vaccine. The company said it plans to launch the vaccine in the country in "the coming days" with commercialization partner Laboratorios...
BC Extra | Jan 29, 2010
Top Story

Sinovac raises $57.5 million

Sinovac Biotech Ltd. (NASDAQ:SVA) raised $57.5 million through the sale of 10 million shares at $5.75 in a bumped-up follow-on underwritten by UBS and Piper Jaffray. Sinovac proposed to sell 8.7 million shares last week,...
BC Extra | Jan 21, 2010
Financial News

Sinovac proposes follow-on

Sinovac Biotech Ltd. (NASDAQ:SVA) proposed late Wednesday to sell 8.7 million shares in a follow-on underwritten by UBS and Piper Jaffray. If sold at Sinovac's Wednesday close of $7.51, the company would raise $65 million....
BC Week In Review | Sep 7, 2009
Company News

Sinovac, Beijing Public Health Bureau infectious news

Sinovac said it is one of the four manufacturers selected by the bureau to supply seasonal influenza A (H1N1) vaccine. Sinovac's Anflu seasonal vaccine is approved in China. The bureau will offer free vaccinations for...
BC Week In Review | Oct 29, 2007
Company News

Sinovac, Beijing Public Health Bureau infectious news

The bureau purchased 140,000 adult doses of SVA's Anflu influenza vaccine for CNY 34 ($4.53) per dose. The bureau has an option to purchase additional doses of the vaccine from SVA. Sinovac Biotech Ltd. (SVA),...
BC Week In Review | Aug 6, 2007
Company News

Sinovac, GlaxoSmithKline sales and marketing update

GSK's GlaxoSmithKline Investment Co. Ltd. unit will distribute the adult dosage formulation of SVA's Anflu influenza vaccine in China. SVA will sell the pediatric formulation. Sinovac Biotech Ltd. (SVA), Beijing, China   GlaxoSmithKline plc (LSE:GSK;...
BioCentury | Oct 17, 2005

Flu vaccine manufacturers

Flu vaccine manufacturers Company Product Description Status Acambis Influenza vaccine (partnered with Flanders InterUniversity) Vaccine protecting against strains A and B; vaccine will contain a cell surface part of the ion channel protein M2, which...
Items per page:
1 - 8 of 8